Samantha Holroyd, a director at $CHRD, bought 1,250 shares of the company on 11-07-2025 for an estimated $106,875. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 7.6%. Following this trade, they now own 17,706 shares of this class of $CHRD stock.
$CHRD Insider Trading Activity
$CHRD insiders have traded $CHRD stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CHRD stock by insiders over the last 6 months:
- SHANNON BROWNING KINNEY (EVP, CAO, GC & Corp Secretary) has made 0 purchases and 2 sales selling 4,019 shares for an estimated $419,933.
- SAMANTHA HOLROYD purchased 1,250 shares for an estimated $106,875
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHRD Hedge Fund Activity
We have seen 218 institutional investors add shares of $CHRD stock to their portfolio, and 240 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 920,136 shares (+inf%) to their portfolio in Q3 2025, for an estimated $91,433,914
- FMR LLC added 906,355 shares (+22.2%) to their portfolio in Q2 2025, for an estimated $87,780,481
- ORION PORFOLIO SOLUTIONS, LLC added 698,680 shares (+6714.2%) to their portfolio in Q2 2025, for an estimated $67,667,158
- AQR CAPITAL MANAGEMENT LLC added 497,789 shares (+210.5%) to their portfolio in Q2 2025, for an estimated $48,210,864
- CITADEL ADVISORS LLC added 392,589 shares (+303.7%) to their portfolio in Q2 2025, for an estimated $38,022,244
- UBS GROUP AG removed 373,272 shares (-44.0%) from their portfolio in Q2 2025, for an estimated $36,151,393
- WOODLINE PARTNERS LP removed 365,845 shares (-96.3%) from their portfolio in Q2 2025, for an estimated $35,432,088
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHRD Congressional Stock Trading
Members of Congress have traded $CHRD stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CHRD stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CHRD Analyst Ratings
Wall Street analysts have issued reports on $CHRD in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 10/17/2025
- Roth Capital issued a "Buy" rating on 10/14/2025
- RBC Capital issued a "Outperform" rating on 10/07/2025
- Piper Sandler issued a "Overweight" rating on 10/03/2025
- UBS issued a "Buy" rating on 09/16/2025
- Mizuho issued a "Outperform" rating on 09/15/2025
- Citigroup issued a "Buy" rating on 07/09/2025
To track analyst ratings and price targets for $CHRD, check out Quiver Quantitative's $CHRD forecast page.
$CHRD Price Targets
Multiple analysts have issued price targets for $CHRD recently. We have seen 10 analysts offer price targets for $CHRD in the last 6 months, with a median target of $129.0.
Here are some recent targets:
- Hanwen Chang from Wells Fargo set a target price of $108.0 on 10/17/2025
- Nick Pope from Roth Capital set a target price of $130.0 on 10/14/2025
- Devin McDermott from Morgan Stanley set a target price of $128.0 on 10/14/2025
- Scott Hanold from RBC Capital set a target price of $135.0 on 10/07/2025
- Mark Lear from Piper Sandler set a target price of $167.0 on 10/03/2025
- Paul Cheng from Scotiabank set a target price of $120.0 on 09/19/2025
- Noah Hungness from B of A Securities set a target price of $123.0 on 09/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
